[RGLS] YoY Annual Result on 31-Dec-2012 [#FY]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
19-Feb-2013
Financial Year
2012
Quarter
31-Dec-2012 [#FY]
Profit Trend
YoY- -128.99%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Annual Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 1,194 20,759 7,669 19,569 12,700 13,789 8,601 -28.02%
PBT -81,840 -55,766 -56,679 -18,691 -17,418 -7,396 -15,589 31.79%
Tax -4 -18 1 -23 -10 206 -30 -28.50%
NP -81,836 -55,748 -56,680 -18,668 -17,408 -7,602 -15,559 31.84%
Tax Rate - - - - - - - -
Total Cost 83,030 76,507 64,349 38,237 30,108 21,391 24,160 22.82%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -6,853.94 -268.55 -739.08 -95.40 -137.07 -55.13 -180.90 83.16%
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -185.94 -130.12 -154.27 -58.22 -254.37 -3,554.00 -7,273.96 -45.69%
EPS Diluted -185.94 -130.12 -154.27 -58.22 -254.37 -3,554.00 -7,273.96 -45.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.